Bioinvent International Ab
Clinical trials sponsored by Bioinvent International Ab, explained in plain language.
-
New combo therapy aims to boost immune attack on tough melanoma
Disease control OngoingThis study tests a new drug, BI-1607, added to two existing immunotherapy drugs (ipilimumab and pembrolizumab) for people with advanced melanoma that has spread or can't be removed. The goal is to see if the combination is safe and helps the immune system fight cancer better. Abo…
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated May 17, 2026 02:18 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-stage trial tests a new drug called BI-1910, alone or with pembrolizumab, in people with advanced solid tumors (like lung or liver cancer) that have stopped responding to standard treatments. The main goals are to check safety, find the best dose, and see if the drug h…
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated May 13, 2026 15:59 UTC